• Journal of Life Science
• /
• v.24 no.6
• /
• pp.677-685
• /
• 2014

The purpose of this study was to identify the effect on plasma levels of lipid and lipid peroxidation by administration of lactic acid bacteria (Lactobacillus bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus) fermented Orostachys malacophyllus (FOM) in alcohol fed rats. Male Sprague-dawley rats were randomly divided into seven groups: normal diet group (N), alcohol treated group (C), 2.5% (w/w) or 5% (w/w) OM treated group (2.5OM, 5OM), 2.5% (w/w) or 5% (w/w) fermented OM treated group (2.5FOM, 5FOM) and silymarin treated group (SM) as a positive control. As a result of measuring serum total lipid, C group were increased total lipid, free fatty acid content and were decreased HDL-cholesterol content, but 5FOM group were significantly decreased lipid content and were increased HDL-cholesterol content and accordingly reduced the incidence of atherosclerosis. Serum total protein content was similarly measured in all groups and serum albumin content was decreased in alcohol feeding groups compared to the N group. The 5FOM group had significantly decreased liver and serum triglycerides compared to the C group. The TBARS content in the liver, serum, testis, kidney, spleen, and heart were slightly decreased in the 5FOM group compared to the C group and the 5FOM group had an increased glutathione concentration. The 5FOM treatment was showed analogous results to those of the SM treatment, suggesting that FOM is can improve the lipid profiles of alcohol-fed rats.

• Proceedings of the Korean Society for Food Science of Animal Resources Conference
• /
• 2004.10a
• /
• pp.367-370
• /
• 2004

본 연구는 콜레스테롤을 제거한 우유에 미세캡슐 키토올리고당을 첨가한 랫트 사료의 섭취량에 따른 체중 증가량, 총 콜레스테롤의 함량과 중성지질, HDL-cholesterol의 함량 변화를 연구하였다. 이 미세캡슐 키토올리고당을 SD 랫트에 매일 섭취시킨 결과HDL-cholesterol의 증가가 높게 나타났다. 본 실험에서, 혈중콜레스테롤 저하 기능이 있는HDL-cholesterol 수치가 증가하는 결과를 나타내므로 혈중 콜레스테롤 저하 기능성 우유로서의 기능이 있다고 사료된다.

• Journal of Life Science
• /
• v.31 no.3
• /
• pp.346-355
• /
• 2021

The purpose of this study was to evaluate the possibility that administration of Bacillus polyfermenticus KJS-2 (BP2), Bacillus mojavensis KJS-3 (Moja3), and their mixtures could control serum lipid levels. We observed changes in the blood cell level, metabolic function evaluation, and blood lipid levels after two weeks of oral administration of these microbial strains to hyperlipidemia-induced rats. Measurements of major cell changes in the white blood cells (WBC) indicated no significant effects due to the administration of the microbial strains. Platelet (PLT) levels decreased by 18.4% in the Triton WR-1339-treated group (NCON) and recovered to the control (CON) group levels in the positive control (PCON) group and the microbial strain-administered groups (p<0.05). No functional changes were observed in red blood cells (RBC) by Triton WR-1339-induced hyperlipidemia. The blood AST, ALT, BUN, and creatinine levels did not indicated effects on liver and kidney function, and all rats administered the microbial mixture recovered. The blood lipid levels in the microbe-treated groups indicated reduced levels of triglyceride (TG) and total cholesterol (TC), and increased levels of serum HDL cholesterol. The HMG-CoA inhibition rate of 7-O-succinyl macrolactin A (SMA) produced by BP2 showed similar activity at a concentration of 1,000 times lower than that achieved with atorvastatin. The administration of the microbial strains to the Triton WR-1339-induced rat model of hyperlipidemia resulted in reduced weight gain without affecting the food and water intake. Thus, blood circulation can be improved by controlling serum lipid levels by the combined administration of the BP2 and Moja3 microbial strains.

• Korean Journal of Clinical Pharmacy
• /
• v.22 no.3
• /
• pp.274-282
• /
• 2012

현재 HIV(human immunodeficiency virus) 감염에 대하여 보다 많은 효과적인 약물치료법이 가능하다. Highly active antiretroviral therapy (HAART)로 언급되는 이 치료법은 항 HIV치료제의 다양한 병용법으로 구성된다. 그러나, 최근에 이렇게 치료된 환자들에게 중요한 독성들(toxicities)로서 빈번하게 상당한 지질이상과 혈중당의 항상성 조절장애와 연관된 몸의 지방 분포 비정상으로서 나타나는, 광범위한 대사성 합병증(metabolic complications)이 출현해왔다. 이러한 합병증의 관리는 표준적인 치료 중재(interventions)와 연관하여 지질과 당 대사와 관련된 항 HIV치료제의 특성 있는 효과를 이해하면서, 항 HIV 약물들을 조절하는 것을 포함한다. 본 증례는 항HIV 약물요법과정에서 나타난 상당한 지질 이상, 매우 높은 LDL 수치와 높은 TG수치에 따르는 후속 약물요법을 보여주며, 개별화된 항 HIV 약물요법을 수행하면서, 대사성 합병증에 관련된 수치의 검사와 주기적인 약물치료과정의 모니터링을 권하여 HIV에 감염된 환자들의 효과적인 치료를 향상시키기 위한 것이다.

• Journal of Life Science
• /
• v.23 no.11
• /
• pp.1371-1380
• /
• 2013

The effect of Monascus-fermented Angelica gigas Nakai (AFAG) on the contents of serum lipids and tissue lipid peroxidation was investigated in alcohol feeding rats (Alc group). The serum contents of total lipid and free fatty acid in the alcohol feeding rats were significantly increased, but these increases tended to decrease in the AFAG group. The content of serum triglyceride was also significantly decreased in the AFAG group compared to the other groups. The serum content of total-cholesterol was not significantly different between the normal group and the AFAG group. The content of HDL-cholesterol in serum was slightly increased in the AFAG group compared to the Alc group. The content of thiobarbituric acid reactive substances (TBARS) in the liver, heart, spleen, and testis were significantly increased in the Alc group compared to the normal group, but these increases were significantly decreased in the AFAG group. The content of liver zinc was decreased in the Alc group and it was significantly increased in the AFAG group, which suggested that the lipid peroxidation contents are inversely correlated with the liver zinc content. The hepatic glutathione concentration was significantly decreased in the Alc group, but this content was significantly increased in the AFAG group, and it showed the antioxidant ability of glutathione. These activities were also compared to the standard silymarin drug treatment. Thus, the findings of the present study indicated the significant antioxidant and antihyperlipidemic activity of Monascus-fermented Angelica gigas Nakai against ethanol-induced toxicity.

• Proceedings of the Korean Society for Food Science of Animal Resources Conference
• /
• 2004.10a
• /
• pp.349-353
• /
• 2004

본 연구에서는 ${\beta}-CD$를 이용하여 우유에서 콜레스테롤을 제거한 후 혈중 콜레스테롤 저하를 위해 EPO을 첨가하였다. EPO의 첨가량에 따른 우유의 저장 중 이화학적 변화와 관능적 특성들을 살펴보았으며 동물실험을 통해 랫트 사료의 섭취량에 따른 체중 증가량, 총 콜레스테롤의 함량과 중성지질, HDL-cholesterol의 함량 변화로 혈중 콜레스테롤 저하효과를 증명하였다. 우유의 지방산화도는 EPO의 첨가량이 증가되고 저장기간이 경과할수록 높아지는 결과가 나타났다. 관능평가에서는 저장 기간동안 EPO를 첨가한 우유는 소량 첨가시 매우 양호 하였으나 첨가량이 많을수록, 저장기간이 경과할수록 바람직하지 않은 결과를 나타내었다. 동물실험에서 EPO를 첨가한 우유를 매일 섭취시킨 랫트에서 HDL-cholesterol의 증가를 나타냈다. 결과적으로 ${\beta}-CD$로 콜레스테롤을 제거한 후 EPO를 첨가시킨 우유는 저장기간이 경과함에 따라 이화학적, 관능적 특성에 적은 변화가 있었고 관능평가에서도 적은 영향을 주었으며 동물실험에서는 혈중 콜레스테롤 저하기능이 있는 HDL-cholesterol의 수치가 대폭 증가하는 결과가 나타났으므로 EPO를 첨가한 우유는 혈중 콜레스테롤 저하 기능성 우유로서의 개발이 가능할 것이라고 사료된다.

• The Journal of the Korea Contents Association
• /
• v.17 no.11
• /
• pp.200-208
• /
• 2017

The purpose of this study was to investigate the effects of isometric exercise based MNIT treatment on body composition, blood lipids, leptin and CRP in middle-aged obese women. For this purpose, middle-aged obese women (age: 40-50) with more 30% of body fat percentage in U city were recruited. They were divided into MNIT group(MG, n=9) and control group(CG, n=9). MNIT group was performed hand therapy program with abdomen exercise equivalent to RPE (9-11) (week 1-4) and exercise equivalent to RPE (11-12) (Week 5-8) and exercise equivalent to RPE (12-13) (week 9-12) 60 minutes a day for 3 days a week in 12 weeks. The results of this study were as follows: Body weight, fat mass, and body mass index had a significant lower in MG group than CG. There are no significant changes in blood profiles, and leptin. In conclusion, isometric based on MNIT may lead to development of an alternative therapy for middle-aged obese women.

• Proceedings of the Korean Society for Food Science of Animal Resources Conference
• /
• 2004.10a
• /
• pp.354-357
• /
• 2004

본 연구는 ${\beta}-CD$를 이용하여 콜레스테롤을 제거한 우유에 EPO의 첨가비율을 달리하여 제조한 요구르트의 이화학적 변화와 물성 및 관능적 특성을 알아보는 것과 동물실험을 통해 혈중콜레스테롤 저하 기능을 관찰함으로서 혈중콜레스테롤 저하 요구르트를 개발하기 위하여 실시하였다. ${\beta}-CD$를 이용하여 콜레스테롤을 제거한 우유에 달맞이꽃 종자유를 첨가하여 제조한 요구르트는 저장기간이 지남에 따라 품질이 저하되었으나, control과 유사한 경향을 보여 전체적으로 긍정적인 결과로 나타났으며, 랫트 실험결과 HDL-cholesterol은 대조군과 유의적 차이는 없었지만 EPO를 섭취하기 전보다 21.4mg/dl 증가하였고, 총콜레스테롤 농도와 중성지질의 농도가 감소한 결과로 보아 LDL-cholesterol수치가 저하되었음을 나타내므로 혈중 콜레스테롤 저하 기능성 요구르트로서의 작용을 가지고 있다고 사료된다.

• Journal of Life Science
• /
• v.28 no.1
• /
• pp.58-67
• /
• 2018

This study aimed to identify the effects of extracts of fermented Angelica gigas Nakai (A. gigas) with a Monascus purpureus strain on anti-obesity in a high-fat diet (HFD)-induced obesity rat model. Male Sprague-Dawley rats were randomly divided into seven dietary groups (n=8 per group), as follows: a normal diet group (N) and six HFD groups (C: control, HFD and no treatment; AG: HFD +10% A. gigas extracts; FAG2.5: HFD +2.5% fermented A. gigas extracts; FAG5: HFD +5% fermented A. gigas extracts; FAG10: HFD +10% fermented A. gigas extracts; GC: HFD + Garcinia cambogia extracts). FAG-fed rats exhibited effectively lowered rates of increasing body weight and visceral fat accumulation in the HFD-induced obesity model. The activities of several hepatic marker enzymes, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and alkaline phosphatase (ALP), were increased with HFD-induced obesity, but levels of these marker enzymes were significantly decreased in FAG-fed rats. The consumption of FAG reduced triglyceride concentrations in serum to normal levels. FAG-fed rats showed effectively increased leptin concentrations in the HFD-induced obesity model. HFD ingestion induced a significant increase in the thiobarbituric acid reactive substances (TBARS) levels, which was decreased in FAG-fed rats. Hematoxylin and eosin staining and Oil Red O staining of the liver showed that the lipid deposits were decreased via FAG feeding. Moreover, hematoxylin and eosin staining of epididymal adipose adipose tissue showed that the adipocyte were decreased by feeding FAG.

• Journal of Nutrition and Health
• /
• v.41 no.1
• /
• pp.31-40
• /
• 2008

This study was aimed at evaluating the effect of red-yeast-rice supplementation on cholesterol-lowering and glucose control in subjects with impaired fasting glucose (IFT) or impaired glucose tolerance (IGT). We conducted a doubleblind, placebo-controlled study with 3 groups; placebo, low dose group (red yeast rice 210.0mg/capsule, 2.52g/day) and high dose group (red yeast rice 420.0mg/capsule, 5.04g/day), which were randomly assigned to subjects with impaired fasting glucose or impaired glucose tolerance. We measured fasting serum concentrations of total-, LDL-, HDL-cholesterol, triglyceride, glucose, insulin, free fatty acid (FFA) and 2 h oral glucose tolerence test (OGTT) before and after the supplementation. Both low dose and high dose groups had significant decrease in LDL cholesterol and atherogenic index (AI) compared with placebo group (p<0.05). Additionally, total and HDL cholesterol improved significantly in high dose group compared with placebo group (p<0.05). Fasting serum glucose decreased in test groups and increased in placebo group after intervention. However, it was not significant differences. In subjects which fasting blood glucose is more than 110mg/dL, fasting glucose had a tendency to decrease in high dose group (p<0.1) and Hemoglobin A1c (HbA1c) had significant decrease in low dose group (p<0.05), while insulin and HOMA-IR had a tendency to increase in placebo group after intervention. Mean changes of glucose related parameters (fasting glucose, insulin, HOMA-IR) compared with placebo group did not show significant differences. In conclusion, subjects with impaired fasting glucose or impaired glucose tolerance were significantly improved in serum lipid profile by red yeast rice supplementation without serious side effects. These are more effective in the case of a high dose. The effects of red yeast rice supplementation on glucose control were insignificant.